Table 6. Laboratory values on admission in patients with COVID-19 by intubation and mortality.
Variables | All patients | Intubation | No intubation | P value | Patients died | Patients survived | P value |
---|---|---|---|---|---|---|---|
Lymphocytes (%) | 10.8±8.6 | 8.9±8.3 | 13.1±8.6 | 0.10 | 9.4±8.4 | 11.9±8.7 | 0.33 |
CRP (mg/dL) | 14.6±9.3 | 16.4±9.5 | 12.3±8.6 | 0.13 | 14.5±7.0 | 14.6±10.8 | 0.96 |
PCT (ng/mL) | 0.4 (0.2; 0.8) | 0.4 (0.2; 0.9) | 0.4 (0.2; 0.8) | 0.83 | 0.4 (0.2; 0.6) | 0.4 (0.2; 0.9) | 0.29 |
IL-6 (pg/mL) | 147 (55; 355) | 183 (89; 487) | 99 (33; 175) | 0.021 | 191 (139; 484) | 93 (26; 183) | 0.009 |
D-dimer (µg/mL) | 3.5±4.0 | 3.8±3.2 | 3.0±4.9 | 0.52 | 3.7±3.1 | 3.3±4.6 | 0.77 |
hs-troponin (pg/mL) | 38 (21; 93) | 34 (22; 72) | 57 (14; 149) | 0.76 | 35 (25; 61) | 51 (12; 160) | 0.82 |
NT-proBNP (pg/mL) | 1,681 (426; 3,965) | 1,301 (379; 3,368) | 1,851 (469; 5,517) | 0.09 | 1,082 (279; 2,886) | 1,851 (727; 5,517) | 0.09 |
LDH (U/L) | 538 (424; 688) | 629 (449; 771) | 470 (410; 545) | 0.026 | 640 (537; 796) | 449 (416; 607) | 0.008 |
Creatinine (mg/dL) | 1.7±1.8 | 1.6±2.0 | 1.9±1.9 | 0.56 | 1.4±1.3 | 2.0±2.3 | 0.29 |
Data were presented as mean ± standard deviation or median days (IQR) if not otherwise specified. COVID-19, coronavirus disease 2019; CRP, C-reactive protein; PCT, procalcitonin; IL-6, interleukin-6; hs, high sensitive; NT-proBNP, N-terminal pro-B-type natriuretic peptide; LDH, lactate dehydrogenase; IQR, interquartile range.